<DOC>
	<DOCNO>NCT00003592</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know whether methotrexate paclitaxel effective treat patient advanced head neck cancer . PURPOSE : Randomized phase III trial compare effectiveness methotrexate paclitaxel treat patient advanced head neck cancer treat cisplatin .</brief_summary>
	<brief_title>Methotrexate Compared With Paclitaxel Treating Patients With Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare progression free survival , median survival , overall survival cisplatin-ineligible patient advance squamous cell carcinoma head neck follow weekly outpatient methotrexate ( arm I ) versus paclitaxel ( arm II ) . II . Compare response rate patient two treatment arm . III . Compare Trial Outcome Index score patient two treatment arm . IV . Compare weight change , neurologic toxicity , mucositis score patient two treatment arm . OUTLINE : This randomize study . Patients stratify performance status ( 0-1 v 2 ) age ( le 60 v least 60 ) . Patients randomize receive methotrexate IV bolus every week 4 week ( arm I ) paclitaxel IV 1 hour every week 4 week ( arm II ) . All patient receive least 4 week treatment ( 1 course ) . Patients continue treatment total 6 course absence disease progression unacceptable toxicity . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : There 230 patient accrue study 2.4 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced , incurable , squamous cell carcinoma head neck Recurrent disease previously irradiated field must biopsy proven document unequivocally physical exam radiograph ( ) Measurable evaluable disease Patients ECOG performance status 01 must ineligible protocol E1395 unable tolerate cisplatinbased therapy 1 follow reason : Hearing loss precludes cisplatin Unable handle fluid load necessitate cisplatinbased treatment , due underlie cardiac pulmonary disease Mild renal insufficiency ( creatinine 1.62.0 mg/dL ) creatinine clearance 4060 mL/min would make cisplatin treatment difficult , dangerous History brain metastasis allow disease stabilize improve radiation and/or craniotomy No history carcinomatous meningitis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 ( See Disease Characteristics ) Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,800/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL SGOT SGPT great 5 time upper limit normal Renal : See Disease Characteristics Creatinine great 2.0 mg/dL No evidence symptomatic hypercalcemia Cardiovascular : See Disease Characteristics No active angina uncontrolled arrhythmias Metabolic : No uncontrolled diabetes ; random blood sugar least 300 mg/dL Neurological : No evidence ongoing grade 2 great peripheral sensory neuropathy Pulmonary : See Disease Characteristics Other : No concurrent , active , invasive malignancy No significant detectable infection Not pregnant nursing Effective contraception require fertile patient PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy except adjuvant , neoadjuvant , radiosensitizing set No prior chemotherapy recurrent persistent disease definitive local therapy At least 6 month since prior methotrexate paclitaxel Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy Surgery : See Disease Characteristics Recovered prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>